De hyppigst rapporterede bivirkninger var oftest af let til moderat sværhedsgrad og kunne klares uden behov for dosisjusteringer eller behandlingsophør.
The most frequently reported adverse reactions were mostly mild to moderate in severity and were manageable without the need for modification of doses or discontinuation of therapy.